LUO Qiong, et al. Study on analgesic effect of rofecoxib on patients with advanced carcinoma. [J]. Journal of Chongqing Medical University (6):825-826(2004)
LUO Qiong, et al. Study on analgesic effect of rofecoxib on patients with advanced carcinoma. [J]. Journal of Chongqing Medical University (6):825-826(2004) DOI: 10.13406/j.cnki.cyxb.2004.06.038.
Study on analgesic effect of rofecoxib on patients with advanced carcinoma
Objective:To study the analgesic effect of rofecoxib on patients with advanced carcinoma.Methods:In a randomized clinical trial
108 pathologically diagnosed cancer patients were treated with rofecoxib(dose 25~50mg/d) and the pain relief was observed among all the patients.Results:Rofecoxib was effective in control of cancer related pain in an oral dose of 25~50mg/day with a total effective rate of 84.26%.The main adverse reactions such as drowsiness
dizziness
nausea
vomiting
discomfort in stomach and constipation were slight.Conclusion:Rofecoxib is effective for relieving cancer related pain with sustained duration and slight in adverse reaction and convenient for administration.
Clinical efficacy observation of multi-line therapy of inetetamab combined with pyrotinib (China double target) in patients with Her2 positive breast cancer
Related Author
LIAO Bizhen
et al
Cai Shuanglong
Related Institution
Department of Obstetrics and Gynecology,College of Clinical Medicine,Chongqing Medical University
重庆医科大学临床学院妇产科
Department of Oncological Surgery, Fujian Provincial Hospital, Fujian Medical University